Lurosetron

Lurosetron

SCHEMBL30949356

Cc1[nH]cnc1CN1CCc2c(c3cccc(F)c3n2C)C1=O

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.72
CYP1A2 P05177 1/20 0.72
CYP3A4 P08684 1/20 0.72
ADRA2C P18825 1/20 0.72
HTR2A P28223 1/20 0.72
HTR2C P28335 1/20 0.72
ADRA1A P35348 1/20 0.72
HTR2B P41595 1/20 0.72
HTR3A P46098 1/20 0.72
CASP6 P55212 1/20 0.71
CD44 P16070 2/20 0.38
P2RX7 Q99572 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lurosetron SCHEMBL788289 1.00 KCNH2 (0.72) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL7291773 0.99 CASP6 (0.72) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL7336906 0.99 KCNH2 (0.71) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL635328 0.95 KCNH2 (0.66) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL7336554 0.95 KCNH2 (0.65) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL7282816 0.93 KCNH2 (0.63) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL9486016 0.93 KCNH2 (0.63) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
Lurosetron SCHEMBL7284073 0.92 KCNH2 (0.65) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
SCHEMBL7285588 0.90 KCNH2 (0.74) KCNH2CYP1A2CYP3A4ADRA2CHTR2A
SCHEMBL7293493 0.88 KCNH2 (0.72) KCNH2CYP1A2CYP3A4ADRA2CHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288545-A1 NEOSTIGMINE COMBINATIONS AND COMPOSITIONS DAS-MG, INC. 2025-09-18 US disclosed
CN-118681024-A Compositions and methods for treating depression 才思治疗公司 2024-09-24 CN disclosed
CN-110719778-B Compositions and methods for treating depression 才思治疗公司 2024-06-18 CN disclosed